http://dietspotlight.com This is a dietspotlight.com review of Contrave. On Feb 2, 2001, the FDA rejected Orexigen Therapeutics Inc.'s Contrave pill, citing fears that the pill may increase heart risk. The FDA has not approved a new weight loss medication in ten years.
Link to this comment:
All Comments (0)